The Science Behind Fast, Lasting, Powerful Pain Relief & Much More with Industry-Leading Clinical Research Results


Optimize Blood Circulation for a Variety of Significant Outcomes!



BUY MY D'OXYVA




When nothing else works, as your first line of defense, target the underlying cause now with D'OXYVA.




In various clinical studies, D'OXYVA® (deoxyhemoglobin vasodilator) has achieved over 90%* elimination of all sorts of chronic pain in 100% of subjects either the same day or in a few days, such as from a very high 8 to a very low 1 on the Visual Analog Scale (VAS).

*Average results rounded for display, based on number of enrolled subjects in each clinical study with D'OXYVA.
Read D'OXYVA Clinical Evidence








Pain-free life is here. Beyond major clinical outcomes for mild to extremely severe conditions, even when strong opioid-based painkillers were ineffective, new and long-term users of D'OXYVA® reported relief of persistent long-term chronic pain in 2 - 7 days associated with:

    Neuropathy

    Fibromyalgia

    Chemo-, and radiation therapy

    Chronic wounds

    Arthritis, osteoporosis

    Migraine headaches

    Lower back









Impaired tissue perfusion denies oxygen and blood flow where it is needed most, preventing the delivery of nutrients, natural pain relief, and slowing the healing process.


Few people, however, suffer as much from poor circulation as those with high blood sugar, arthritis, osteoarthritis, venous insufficiency, and cardiovascular complications do.


A scientific paper titled Impaired Tissue Perfusion - A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus published in Circulation by the American Heart Association underscores this fact.

















By expert opinion, Circularity Healthcare is bringing about a radical change in the standard of care, transdermal delivery, cardiovascular, and neuroscience widely across the healthcare system.


Circularity has layed the groundwork for an explosion of a large variety of clinical research into entirely new promising treatments, even for rare diseases.



Neuropathies are characterized by a progressive loss of nerve fiber function. A widely accepted definition of diabetic peripheral neuropathy is "the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after exclusion of other causes."


Pain is defined by the International Association of Pain as unpleasant sensory and emotional experience, associated with actual or potential tissue damage, or described in terms of such damage. Pain is always subjective.





Fibromyalgia (FM) is characterized by generalized muscle pain, low muscle strength and autonomic dysfunction.


The autonomic nervous system regulates the ‘automatic’ functions of the body such as heart rate responsiveness to changing physical equirements.


Heart rate variability (HRV) is reduced in individuals with FM increasing their risk for cardiovascular morbidity and mortality.



Complex regional pain syndrome (CRPS) according to the National Institute of Neurological Disorders and Stroke at the National Institutes of Health is when people also experience changes in skin temperature, skin color, or swelling of the affected limb.


This is due to abnormal microcirculation caused by damage to the nerves controlling blood flow and temperature. As a result, an affected arm or leg may feel warmer or cooler compared to the opposite limb. The skin on the affected limb may change color, becoming blotchy, blue, purple, pale, or red.






Microcirculation dysfunction is increasingly regarded by the mainstream medical, scientific, cosmetic, and alternative health care community as the underlying cause of nearly all health complications for both the young and elderly.


Poor circulation, especially poor microcirculation and its dysfunction in these people often result in high blood pressure, hypertension, neuropathy pain, ulcers, and even necrosis.


Restrictions in this form of circulation impede the flow of antibodies, white blood cells and platelets, and rob the skin and tissues of oxygen and much needed nutrients.






D'OXYVA (deoxyhemoglobin vasodilator)


Researchers are continuously seeking out solutions that reduce these symptoms, and recent clinical research has revealed a uniquely promising, affordable, and non-opioid solution.


D'OXYVA advanced, non-invasive, and non-opioid biotech solution has demonstrated significantly strengthening the body’s natural healing foundation: the autonomic nervous system (parasympathetic nerve activity) and the microcirculatory system.




D'OXYVA has been demonstrating fast, lasting, and powerful pain relief and numerous major health benefits in record time.





D'OXYVA's results have been successfully reproduced by other studies. Victims of neuropathy, peripheral vascular complications, bodily injury, surgical complications, and various forms of chronic pain reported significant reduction in symptoms and pain in 9 out of 10 cases. Typically doing so within a week, from an 8 to 1 on the Visual Analog Scale (VAS) by taking it once or twice a day.
Press release





Select the color of your D'OXYVA® - target the cause of your pain & condition without negative side effects






Back to Top ^


A Variety of Significant Outcomes Through Improved Tissue Perfusion


As the summary abstract presented at the 2013 Diabetic Foot Global Conference describes on this page, in a pilot study all subjects received a painless, five-minute D'OXYVA delivery through their thumb and their Skin Perfusion Pressure (i.e., microcirculation) was measured periodically for four hours afterward.

Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D'OXYVA was administered.



All subjects recorded significant increases in Skin Perfusion Pressure (i.e., microcirculation). In fact, nearly 33%* increase on average from absolute baseline during the four hours after administration, which is groundbreaking in its field. Both systolic and diastolic blood pressures were significantly reduced over thirty to sixty minutes and sustained over four hours by an average 25* points from absolute baseline.


Circularity has assembled a Scientific Advisory Board (click for partial list) that includes domestic and international medical thought-leaders in the field of diabetic relief, wound healing, microvascular physiology, neurobiology, endocrinology, amputation prevention, vascular surgery, cardiovascular physiology, and others.


They were asked investigating the administration of gas molecules (gasotransmitters) already found in our bodies naturally in a non-traditional way. Rather than working through inhalation or needle injection, D'OXYVA is administered directly on the skin.


More clinical trials are under way to determine additional benefits, but these results thus far are extremely promising and indicating treatment for a variety of disease states related to deficiencies of blood circulation, autonomic nervous system, and cellular, vascular, and tissue regeneration.







Shop All Products

Talk to a Representative
1-855-5DOXYVA
(1-855-536-9982)




Back to Top ^